These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27777975)
21. Bactericidal/Permeability-Increasing Protein Preeminently Mediates Clearance of Theprungsirikul J; Skopelja-Gardner S; Burns AS; Wierzbicki RM; Rigby WFC Front Immunol; 2021; 12():659523. PubMed ID: 33981306 [TBL] [Abstract][Full Text] [Related]
22. IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction. Yadav R; Linnemann RW; Kahlenberg JM; Bridges LS; Stecenko AA; Rada B Autoimmunity; 2020 Dec; 53(8):476-484. PubMed ID: 33258386 [TBL] [Abstract][Full Text] [Related]
23. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905 [TBL] [Abstract][Full Text] [Related]
24. Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity. Linnemann RW; Yadav R; Zhang C; Sarr D; Rada B; Stecenko AA Autoimmunity; 2022 Mar; 55(2):109-117. PubMed ID: 35199621 [TBL] [Abstract][Full Text] [Related]
25. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes. Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966 [TBL] [Abstract][Full Text] [Related]
26. Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Skopelja-Gardner S; Theprungsirikul J; Meagher RE; Beliveau CM; Bradley KE; Avery M; Henkle E; Siegel S; Gifford AH; Winthrop KL; Rigby WFC Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30385530 [No Abstract] [Full Text] [Related]
27. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa. Sedivá A; Bartůnková J; Bartosová J; Jennette C; Falk RJ; Jethwa HS Microbes Infect; 2003 Jan; 5(1):27-30. PubMed ID: 12593970 [TBL] [Abstract][Full Text] [Related]
28. Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis. McQuillan K; Gargoum F; Murphy MP; McElvaney OJ; McElvaney NG; Reeves EP Front Pharmacol; 2020; 11():1098. PubMed ID: 32765284 [TBL] [Abstract][Full Text] [Related]
29. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro. Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661 [TBL] [Abstract][Full Text] [Related]
30. Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement. Wada Y; Kuroda T; Murasawa A; Nakano M; Narita I Mod Rheumatol; 2010 Jun; 20(3):252-6. PubMed ID: 20107854 [TBL] [Abstract][Full Text] [Related]
31. Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis. Budding K; van de Graaf EA; Hoefnagel T; Hack CE; Otten HG J Cyst Fibros; 2014 May; 13(3):281-8. PubMed ID: 24269518 [TBL] [Abstract][Full Text] [Related]
32. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study. Janssen KM; de Smit MJ; Brouwer E; de Kok FA; Kraan J; Altenburg J; Verheul MK; Trouw LA; van Winkelhoff AJ; Vissink A; Westra J Arthritis Res Ther; 2015 Jul; 17(1):174. PubMed ID: 26155788 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis. Lachenal F; Nkana K; Nove-Josserand R; Fabien N; Durieu I Eur Respir J; 2009 Nov; 34(5):1079-85. PubMed ID: 19443536 [TBL] [Abstract][Full Text] [Related]
34. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA. Jovic S; Linge HM; Shikhagaie MM; Olin AI; Lannefors L; Erjefält JS; Mörgelin M; Egesten A Mucosal Immunol; 2016 Jan; 9(1):112-23. PubMed ID: 25993443 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Skopelja-Gardner S; Theprungsirikul J; Lewis KA; Hammond JH; Carlson KM; Hazlett HF; Nymon A; Nguyen D; Berwin BL; Hogan DA; Rigby WFC Front Immunol; 2019; 10():1670. PubMed ID: 31379861 [No Abstract] [Full Text] [Related]
37. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies. Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822 [TBL] [Abstract][Full Text] [Related]
38. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical. Boeters DM; Mangnus L; Ajeganova S; Lindqvist E; Svensson B; Toes REM; Trouw LA; Huizinga TWJ; Berenbaum F; Morel J; Rantapää-Dahlqvist S; van der Helm-van Mil AHM Arthritis Res Ther; 2017 May; 19(1):115. PubMed ID: 28569212 [TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa isolates from cystic fibrosis patients induce neutrophil extracellular traps with different morphologies that could correlate with their disease severity. Martínez-Alemán S; Bustamante AE; Jimenez-Valdes RJ; González GM; Sánchez-González A Int J Med Microbiol; 2020 Oct; 310(7):151451. PubMed ID: 33092695 [TBL] [Abstract][Full Text] [Related]
40. Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis. Okamoto Y; Devoe S; Seto N; Minarchick V; Wilson T; Rothfuss HM; Mohning MP; Arbet J; Kroehl M; Visser A; August J; Thomas SM; Charry LL; Fleischer C; Feser ML; Frazer-Abel AA; Norris JM; Cherrington BD; Janssen WJ; Kaplan MJ; Deane KD; Holers VM; Demoruelle MK Arthritis Rheumatol; 2022 Jan; 74(1):38-48. PubMed ID: 34369110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]